Improving Patient Adherence and Quality of Life in Multiple Sclerosis: Strategies for Managing Adverse Events Associated with New and Emerging Therapies

A continuing medical education activity provided by NAMCP and AAMCN

Managing Clinical and Cost Outcomes in Multiple Sclerosis: Utilizing Data to Make
Informed Decisions in Managed Care is a three-part webinar series

This is Part 3 of the series focusing on Improving patient adherence and quality of life

This activity is an archive from the webinar held December 1, 2020

This activity is valid from January 1, 2021 to January 1, 2023

Instructions for CME/NCPD: Complete the pre-test, listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. You will be asked to enter your name and email address on the pre-test, evaluation and post-test. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete. A score of 70% must be achieved on the post test to receive continuing education credits. If you do not pass the post test after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate.

To print or save your certificate, you will need to click on the “download” button and either print or save.


Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This activity is supported by educational grants from
Biogen, Novartis and Sanofi Genzyme

Multiple Sclerosis (MS) is a chronic progressive disease. It is the most common neurological cause of disability among young adults, with a prevalence of approximately one million cases throughout the United States. Although there is still no cure for MS, many advances in MS treatment have arrived in recent years, allowing patients to manage these symptoms and improve their quality of life. Effective and timely treatment of MS can greatly improve the quality of life in MS patients. With the advancement and complexity of different treatment options, including therapies that have recently become available, managed care professionals are being challenged to make informed decisions in their organizations and provide the correct treatment options that are available to patients.

Upon completion of this activity, participants will be able to:

  • Examine challenges to patient adherence, dosing and quality of life in multiple sclerosis and adverse event management

  • Review strategies to monitor and manage adverse events associated with newer therapies, including S1P therapies and anti-CD-20 monoclonal antibodies, in MS in order to improve patient adherence and quality of life

  • Explore the role of subcutaneous administration methods in new and emerging therapies in MS

  • Identify and develop strategies to overcome potential barriers that affect timely access of MS disease-modifying therapies (DMTs) for patients through managed care organizations


Faculty: Fred D. Lublin, MD, FAAN, FANA
Saunders Family Professor of Neurology
Director, The Corinne Goldsmith Dickinson Center for Multiple Sclerosis
Icahn School of Medicine at Mount Sinai


Dr. Lublin serves as a consultant for Biogen; EMD Serono; Novartis; Actelion/Janssen; Sanofi/Genzyme; Roche/Genentech; MedImmune/ Viela Bio; Receptos/Celgene/BMS; TG Therapeutics; Medday; Atara Biotherapeutics; Innate Immunotherapeutics; Apitope; Orion Biotechnology; Brainstorm Cell Therapeutics; Jazz Pharmaceuticals; GW Pharma; Mylan; Immunic; Population Council; Avotres; Neurogene. He has received grants/research support from Novartis; Actelion; Biogen; Sanofi, NMSS, NIH; Brainstorm Cell Therapeutics. His presentation has been peer reviewed for any bias.
  Planning Committee:
Bill Williams, MD has no real or perceived financial relationships to disclose.
Jeremy Williams has no real or perceived financial relationships to disclose.
Jacqueline Cole, RN, MS, CMCN has no real or perceived financial relationships to disclose.

NAMCP and/or the presenter has copyright or has received permissions for use of materials provided in this activity.

Accreditation & Designation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association of Managed Care Physicians (NAMCP) and American Association of Managed Care Nurses (AAMCN). The National Association of Managed Care Physicians is accredited by the ACCME to provide continuing medical education for physicians.

NAMCP designates this enduring material for a maximum of 1 AMA PRA Category 1 credit(s)TM. Each
physician should claim credit commensurate with the extent of their participation in the activity.

The American Association of Managed Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

Nurses who complete this activity and achieve a passing score will receive 1 hour in nursing continuing professional development.

This activity has been approved by the American Board of Managed Care Nursing for 1.0 contact hours toward CMCN recertification requirements.

This activity is supported by educational grants from
Biogen, Novartis and Sanofi Genzyme

NAMCP and/or this website does not provide medical advice, diagnosis or treatment. NAMCP does not endorse or imply endorsement of the content on any linked website. This website is to be used as an informational resource. With any health related concern, consult with your physician or healthcare professional.

Click Here To Continue